[1] Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1

[2] Immunity and immunopathology to respiratory syncytial virus. The mouse model

[3] Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus

[4] Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

[5] Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

[6] Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

[7] Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia

[8] Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment